During the past decade, Clinique specialise Menara; Oncology Medical conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Clinique specialise Menara; Oncology Medical" are "Esophageal Squamous Cell Carcinoma" (1 trials) and "Triple Negative Breast Neoplasms" (1 trials). Many other conditions were trialed in "Clinique specialise Menara; Oncology Medical" in a lesser frequency.

Most popular intervention types in "Clinique specialise Menara; Oncology Medical" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Atezolizumab Matching Placebo" (1 trials), "Capecitabine" (1 trials), "Carboplatin" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique specialise Menara; Oncology Medical" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Clinique specialise Menara; Oncology Medical". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Clinique specialise Menara; Oncology Medical, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinique specialise Menara; Oncology Medical, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".